Robust generation and expansion of skeletal muscle progenitors and myocytes from human pluripotent stem cells

Methods

Volumn 101, Issue , 2016, Pages 73-84

  Shelton, Michael ^a   Kocharyan, Avetik ^a,b   Liu, Jun ^a   Skerjanc, Ilona S ^a   Stanford, William L ^a,b,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

CHIR99021; Embryonic stem cells; Induced pluripotent stem cells; Myogenesis; PAX7; Skeletal muscle

Indexed keywords

ASCORBIC ACID; BICARBONATE; CITRIC ACID; COLLAGENASE; COLLAGENASE IV; EDETIC ACID; FIBROBLAST GROWTH FACTOR 2; GLYCEROL; INSULIN; MONOTHIOGLYCEROL; MYOGENIC FACTOR 5; SODIUM SELENITE; TRANSCRIPTION FACTOR PAX7; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL DENSITY; CELL DIFFERENTIATION; CELL EXPANSION; CELL MATURATION; CELL PLATING DENSITY; CELL PROLIFERATION; CELL STIMULATION; CELL SUSPENSION; CLINICAL PROTOCOL; CONTROLLED STUDY; DISSOCIATION; EPITHELIAL MESENCHYMAL TRANSITION; EXPERIMENTAL DESIGN; GENE; HUMAN; HUMAN CELL; IN VITRO STUDY; MESODERM; MOLECULAR DYNAMICS; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE STEM CELL; MYH3 GENE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE STEM CELL; CELL CULTURE TECHNIQUE; FLUORESCENCE MICROSCOPY; HUMAN EMBRYONIC STEM CELL; INDIRECT FLUORESCENT ANTIBODY TECHNIQUE; INDUCED PLURIPOTENT STEM CELL; MYOBLAST; PHYSIOLOGY;

CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMAN EMBRYONIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICROSCOPY, FLUORESCENCE; MUSCLE CELLS; MYOBLASTS;

EID: 84945572389     PISSN: 10462023     EISSN: 10959130     Source Type: Journal    
DOI: 10.1016/j.ymeth.2015.09.019     Document Type: Article

References (37)

1. Cao N., Liang H., Huang J., Wang J., Chen Y., Chen Z., Yang H.-T. Highly efficient induction and long-term maintenance of multipotent cardiovascular progenitors from human pluripotent stem cells under defined conditions. Cell Res. 2013, 23:1119-1132.
2. Kattman S.J., Witty A.D., Gagliardi M., Dubois N.C., Niapour M., Hotta A., Ellis J., Keller G. Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 2011, 8:228-240.
3. Lian X., Hsiao C., Wilson G., Zhu K., Hazeltine L.B., Azarin S.M., Raval K.K., Zhang J., Kamp T.J., Palecek S.P. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc. Natl. Acad. Sci. U.S.A. 2012, 109. E1848-57.
4. Schwartz S.D., Hubschman J.-P., Heilwell G., Franco-Cardenas V., Pan C.K., Ostrick R.M., Mickunas E., Gay R., Klimanskaya I., Lanza R. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 2012, 379:713-720.
5. Schwartz S.D., Regillo C.D., Lam B.L., Eliott D., Rosenfeld P.J., Gregori N.Z., Hubschman J.-P., Davis J.L., Heilwell G., Spirn M., Maguire J., Gay R., Bateman J., Ostrick R.M., Morris D., Vincent M., Anglade E., Del Priore L.V., Lanza R. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies. Lancet 2015, 385:509-516.
6. Shelton M.L., Metz J., Liu J., Carpenedo R.L., Demers S.-P., Stanford W.L., Skerjanc I.S. Derivation and expansion of PAX7-positive muscle progenitors from human and mouse embryonic stem cells. Stem Cell Rep. 2014, 3:516-529.
7. Borchin B., Chen J., Barberi T. Derivation and FACS-mediated purification of PAX3+/PAX7+ skeletal muscle precursors from human pluripotent stem cells. Stem Cell Rep. 2013, 1:620-631.
8. Xu C., Tabebordbar M., Iovino S., Ciarlo C., Liu J., Castiglioni A., Price E., Liu M., Barton E.R., Kahn C.R., Wagers A.J., Zon L.I. A zebrafish embryo culture system defines factors that promote vertebrate myogenesis across species. Cell 2013, 155:909-921.
9. Hosoyama T., McGivern J.V., Van Dyke J.M., Ebert A.D., Suzuki M. Derivation of myogenic progenitors directly from human pluripotent stem cells using a sphere-based culture. Stem Cells Transl. Med. 2014, 3:564-574.
10. Theodoris C.V., Li M., White M.P., Liu L., He D., Pollard K.S., Bruneau B.G., Srivastava D. Human disease modeling reveals integrated transcriptional and epigenetic mechanisms of NOTCH1 haploinsufficiency. Cell 2015, 160:1072-1086.
11. Chong J.J.H., Yang X., Don C.W., Minami E., Liu Y.-W., Weyers J.J., Mahoney W.M., Van Biber B., Cook S.M., Palpant N.J., Gantz J.A., Fugate J.A., Muskheli V., Gough G.M., Vogel K.W., Astley C.A., Hotchkiss C.E., Baldessari A., Pabon L., Reinecke H., Gill E.A., Nelson V., Kiem H.-P., Laflamme M.A., Murry C.E. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 2014, 510:273-277.
12. Murry C.E., Keller G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 2008, 132:661-680.
13. Relaix F. Skeletal muscle progenitor cells: from embryo to adult. Cell. Mol. Life Sci. 2006, 63:1221-1225.
14. Sakurai H., Okawa Y., Inami Y., Nishio N., Isobe K. Paraxial mesodermal progenitors derived from mouse embryonic stem cells contribute to muscle regeneration via differentiation into muscle satellite cells. Stem Cells 2008, 26:1865-1873.
15. Chang H., Yoshimoto M., Umeda K., Iwasa T., Mizuno Y., Fukada S., Yamamoto H., Motohashi N., Miyagoe-Suzuki Y., Takeda S., Heike T., Nakahata T. Generation of transplantable, functional satellite-like cells from mouse embryonic stem cells. FASEB J. 2009, 23:1907-1919.
16. Awaya T., Kato T., Mizuno Y., Chang H., Niwa A., Umeda K., Nakahata T., Heike T. Selective development of myogenic mesenchymal cells from human embryonic and induced pluripotent stem cells. PLoS One 2012, 7:e51638.
17. Hwang Y., Suk S., Lin S., Tierney M., Du B., Seo T., Mitchell A., Sacco A., Varghese S. Directed in vitro myogenesis of human embryonic stem cells and their in vivo engraftment. PLoS One 2013, 8:e72023.
18. Kennedy K.A.M., Porter T., Mehta V., Ryan S.D., Price F., Peshdary V., Karamboulas C., Savage J., Drysdale T.A., Li S.-C., Bennett S.A.L., Skerjanc I.S. Retinoic acid enhances skeletal muscle progenitor formation and bypasses inhibition by bone morphogenetic protein 4 but not dominant negative beta-catenin. BMC Biol. 2009, 7:67.
19. Ryan T., Liu J., Chu A., Wang L., Blais A., Skerjanc I.S. Retinoic acid enhances skeletal myogenesis in human embryonic stem cells by expanding the premyogenic progenitor population. Stem Cell Rev. Rep. 2012, 8:482-493.
20. Chargé S.B.P., Rudnicki M.A. Cellular and molecular regulation of muscle regeneration. Physiol. Rev. 2004, 84:209-238.
21. Chen G., Gulbranson D.R., Hou Z., Bolin J.M., Ruotti V., Probasco M.D., Smuga-Otto K., Howden S.E., Diol N.R., Propson N.E., Wagner R., Lee G.O., Antosiewicz-Bourget J., Teng J.M.C., Thomson J.A. Chemically defined conditions for human iPSC derivation and culture. Nat. Methods 2011, 8:424-429.
22. Beers J., Gulbranson D.R., George N., Siniscalchi L.I., Jones J., Thomson J.A., Chen G. Passaging and colony expansion of human pluripotent stem cells by enzyme-free dissociation in chemically defined culture conditions. Nat. Protoc. 2012, 7:2029-2040.
23. Gauthaman K., Fong C.-Y., Bongso A. Effect of ROCK inhibitor Y-27632 on normal and variant human embryonic stem cells (hESCs) in vitro: its benefits in hESC expansion. Stem Cell Rev. 2010, 6:86-95.
24. Tan J.Y., Sriram G., Rufaihah A.J., Neoh K.G., Cao T. Efficient derivation of lateral plate and paraxial mesoderm subtypes from human embryonic stem cells through GSKi-mediated differentiation. Stem Cells Dev. 2013, 22:1893-1906.
25. Yoon J.K., Moon R.T., Wold B. The bHLH class protein pMesogenin1 can specify paraxial mesoderm phenotypes. Dev. Biol. 2000, 222:376-391.
26. Chapman D.L., Agulnik I., Hancock S., Silver L.M., Papaioannou V.E. Tbx6, a mouse T-Box gene implicated in paraxial mesoderm formation at gastrulation. Dev. Biol. 1996, 180:534-542.
27. Hall J.K., Banks G.B., Chamberlain J.S., Olwin B.B. Prevention of muscle aging by myofiber-associated satellite cell transplantation. Sci. Transl. Med. 2010, 2:57ra83.
28. Chang W.Y., Lavoie J.R., Kwon S.Y., Chen Z., Manias J.L., Behbahani J., Ling V., Kandel R.A., Stewart D.J., Stanford W.L. Feeder-independent derivation of induced-pluripotent stem cells from peripheral blood endothelial progenitor cells. Stem Cell Res. 2013, 10:195-202.
29. Kinnear C., Chang W.Y., Khattak S., Hinek A., Thompson T., de Carvalho Rodrigues D., Kennedy K., Mahmut N., Pasceri P., Stanford W.L., Ellis J., Mital S. Modeling and rescue of the vascular phenotype of Williams-Beuren syndrome in patient induced pluripotent stem cells. Stem Cells Transl. Med. 2013, 2:2-15.
30. Skuk D., Goulet M., Roy B., Chapdelaine P., Bouchard J.-P., Roy R., Dugré F.J., Sylvain M., Lachance J.-G., Deschênes L., Senay H., Tremblay J.P. Dystrophin expression in muscles of duchenne muscular dystrophy patients after high-density injections of normal myogenic cells. J. Neuropathol. Exp. Neurol. 2006, 65:371-386.
31. Madden L., Juhas M., Kraus W.E., Truskey G.A., Bursac N. Bioengineered human myobundles mimic clinical responses of skeletal muscle to drugs. Elife 2015, 4:e04885.
32. Osafune K., Caron L., Borowiak M., Martinez R.J., Fitz-Gerald C.S., Sato Y., Cowan C.A., Chien K.R., Melton D.A. Marked differences in differentiation propensity among human embryonic stem cell lines. Nat. Biotechnol. 2008, 26:313-315.
33. Chen X.-M., Kan Q.-C., Wang F., Kong H.-J., Zhang Y.-Y., Yu W.-Z., Sun Y.-P. Chromosome dynamic changes in two cultured Chinese human embryonic stem cell lines: single nucleotide polymorphism, copy number variation and loss of heterozygosity. J. Cell. Biochem. 2012, 113:3520-3527.
34. Närvä E., Autio R., Rahkonen N., Kong L., Harrison N., Kitsberg D., Borghese L., Itskovitz-Eldor J., Rasool O., Dvorak P., Hovatta O., Otonkoski T., Tuuri T., Cui W., Brüstle O., Baker D., Maltby E., Moore H.D., Benvenisty N., Andrews P.W., Yli-Harja O., Lahesmaa R. High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nat. Biotechnol. 2010, 28:371-377.
35. Garitaonandia I., Amir H., Boscolo F.S., Wambua G.K., Schultheisz H.L., Sabatini K., Morey R., Waltz S., Wang Y.-C., Tran H., Leonardo T.R., Nazor K., Slavin I., Lynch C., Li Y., Coleman R., Gallego Romero I., Altun G., Reynolds D., Dalton S., Parast M., Loring J.F., Laurent L.C. Increased risk of genetic and epigenetic instability in human embryonic stem cells associated with specific culture conditions. PLoS One 2015, 10:e0118307.
36. Allegrucci C., Wu Y.-Z., Thurston A., Denning C.N., Priddle H., Mummery C.L., Ward-van Oostwaard D., Andrews P.W., Stojkovic M., Smith N., Parkin T., Jones M.E., Warren G., Yu L., Brena R.M., Plass C., Young L.E. Restriction landmark genome scanning identifies culture-induced DNA methylation instability in the human embryonic stem cell epigenome. Hum. Mol. Genet. 2007, 16:1253-1268.
37. Chal J., Oginuma M., Al Tanoury Z., Gobert B., Sumara O., Hick A., Bousson F., Zidouni Y., Mursch C., Moncuquet P., Tassy O., Vincent S., Miyanari A., Bera A., Garnier J.-M., Guevara G., Hestin M., Kennedy L., Hayashi S., Drayton B., Cherrier T., Gayraud-Morel B., Gussoni E., Relaix F., Tajbakhsh S., Pourquié O. Differentiation of pluripotent stem cells to muscle fiber to model Duchenne muscular dystrophy. Nat. Biotechnol. 2015, 33:962-969.